Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
NCT00916695 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 332
Last updated 2009-07-23
Summary
The purpose of this study is to evaluate the efficacy and safety of the treatment of true bifurcation lesions with the XIENCE V stent using the simple strategy (stent in main vessel and provisional T-stenting in the side branch) compared to the complex strategy (stent in main vessel and T-stenting in the side branch).
Conditions
Interventions
- DEVICE
-
Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.
Complex PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), and subsequent implanting of the stent in the main vessel, the side branch is approached by implanting a new stent as T technique. Simple PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), a stent is deployed at main vessel. Side branch is approached by using provisional T stenting technique.
Sponsors & Collaborators
-
Spanish Society of Cardiology
lead OTHER
Principal Investigators
-
Federico Gimeno, MD · Hospital Clinico Universitario Valladolid
-
Bruno Garcia, MD · Hospital Valle de Hebron. Barcelona
-
Ramiro Trillo, MD · Hospital Clínico Santiago
-
Jose Moreu, MD · Hospital Virgen de la Salud
-
Javier Goicolea, MD · Hospital Puerta de Hierro, Madrid
-
Raul Moreno, MD · Hospital Universitario La Paz
-
Jose F Diaz, MD · Hospital Juan Ramon Jimenez. Huelva
-
Jose M Hernandez, MD · Hospital Clinico de Malaga
-
Ramon Lopez-Palop, MD · Hospital San Juan. Alicante
-
Mariano Valdes, MD · Hospital Universitario Virgen de la Arrixaca
-
Pascual Bordes, MD · Hospital Universitario. Alicante
-
Jose R Rumoroso, MD · Hospital Galdakao. Vizcaya
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- Spain
Study Locations
More Related Trials
-
Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII
NCT02093845 ·Status: UNKNOWN ·Phase: NA
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
NCT01120379 ·Status: COMPLETED
-
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
NCT01201369 ·Status: COMPLETED ·Phase: NA
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)
NCT00676520 ·Status: COMPLETED
-
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
NCT00180479 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT01995487 ·Status: COMPLETED ·Phase: NA
-
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease
NCT01310309 ·Status: COMPLETED
-
SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
NCT00180310 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period
NCT00882219 ·Status: COMPLETED ·Phase: PHASE3
-
Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
NCT06441539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
NCT00997763 ·Status: COMPLETED ·Phase: PHASE4
-
SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System
NCT00180453 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
NCT03875651 ·Status: COMPLETED
-
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
NCT03529006 ·Status: UNKNOWN ·Phase: NA
-
XIENCE V: SPIRIT WOMEN
NCT00496938 ·Status: COMPLETED ·Phase: PHASE4
-
Alpine vs. Xpedition: Evaluation of Stent Delivery System
NCT03451617 ·Status: UNKNOWN ·Phase: NA
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
NCT01665053 ·Status: COMPLETED ·Phase: PHASE3
-
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction
NCT02890589 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453 ·Status: UNKNOWN ·Phase: PHASE4
-
Sirolimus-Eluting Stent Versus Standard Stent in Diabetic
NCT00755443 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
NCT01035450 ·Status: COMPLETED ·Phase: PHASE4
-
Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent
NCT02870140 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.
NCT02099617 ·Status: COMPLETED ·Phase: NA
-
Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI
NCT02770651 ·Status: UNKNOWN